NCT00134355View on ClinicalTrials.gov

Study of PTK787 in the Treatment of Patients With Non-Metastatic Androgen Independent Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

November 30, 2006

Study Completion Date

March 31, 2007

Conditions
Prostate Cancer
Interventions
DRUG

PTK787

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

University of Michigan Rogel Cancer Center

OTHER

NCT00134355 - Study of PTK787 in the Treatment of Patients With Non-Metastatic Androgen Independent Prostate Cancer | Biotech Hunter | Biotech Hunter